StonvexLoading…
StonvexStonvexStonvexCore line items from REGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.61B | $14.34B | $10.46B | $6.70B |
Operating Income | $642.90M | $3.58B | $2.70B | $1.67B |
Net Income | $727.20M | $4.50B | $3.66B | $1.39B |
EPS (Diluted) | $6.75 | $41.48 | $33.61 | $20.02 |
Total Assets | $40.87B | $40.56B | $40.17B | $38.22B |
Total Liabilities | $9.45B | $9.30B | $9.21B | $8.28B |
Cash & Equivalents | $2.96B | $3.12B | $2.51B | $2.00B |
Free Cash Flow OCF − CapEx | $848.30M | $4.08B | $3.16B | $1.74B |
Shares Outstanding | 107.70M | 108.60M | 108.90M | 109.90M |